Infection Surveillance in Intensive Care Patients

This study is ongoing, but not recruiting participants.

First Received: September 12, 2005 No Changes Posted

Sponsored by:	Herlev Hospital
Information provided by:	Herlev Hospital
ClinicalTrials.gov Identifier:	NCT00197847

Purpose

Purpose of the study is to investigate and quantify known and possible new riskfactors for nosocomiel infection and death in the intensive care setting.

As new riskfactors Mannose Binding Lechtin and Procalcitonin are chosen and compared to established riskfactors.

Condition
Infection Pneumonia Sepsis Cross Infection

Study Type:	Observational
Study Design:	Natural History, Longitudinal, Defined Population, Prospective Study

Resource links provided by NLM:

MedlinePlus related topics: Pneumonia Sepsis

U.S. FDA Resources

Further study details as provided by Herlev Hospital:

Estimated Enrollment:	549
Study Start Date:	December 2002
Estimated Study Completion Date:	September 2005

Eligibility

Ages Eligible for Study:	18 Years and older
Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	No

Criteria

Inclusion Criteria:Admission to ICU -

Exclusion Criteria:Absence of informed consent and age less than 18 years

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00197847

Locations

Denmark, Copenhagen Couty
Department of Intensive Care
Copenhagen, Copenhagen Couty, Denmark, DK-2730

Sponsors and Collaborators

Herlev Hospital

Investigators

Principal Investigator:

Dorthe H Olsen, M.D.

Department of Intensive Care, Herlev University Hospital

More Information

No publications provided

Study ID Numbers:	KA 02071
Study First Received:	September 12, 2005
Last Updated:	September 12, 2005
ClinicalTrials.gov Identifier:	NCT00197847 History of Changes
Health Authority:	Denmark: The Regional Committee on Biomedical Research Ethics

Study placed in the following topic categories:

Sepsis
Respiratory Tract Infections
Respiratory Tract Diseases

Lung Diseases
Pneumonia
Cross Infection

Additional relevant MeSH terms:

Communicable Diseases
Respiratory Tract Infections
Respiratory Tract Diseases
Lung Diseases

Infection
Pneumonia
Cross Infection

ClinicalTrials.gov processed this record on September 03, 2009